gatA Antibody

Datasheet

Code	CSB-PA300256XA01EOD
Size	Enquire
Have Questions?	Leave a Message or Start an on-line Chat

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Full Product Name

Rabbit anti-Escherichia coli O157:H7 gatA Polyclonal antibody

Uniprot No.

P69814

Target Names

gatA

Alternative Names

gatA antibody; Z3257 antibody; ECs2897 antibody; PTS system galactitol-specific EIIA component antibody; EIIB-Gat antibody; Galactitol-specific phosphotransferase enzyme IIA component antibody

Raised in

Rabbit

Species Reactivity

Escherichia coli O157:H7

Immunogen

A synthesized peptide derived from Escherichia coli O157:H7 gatA protein

Immunogen Species

Escherichia coli O157:H7

Conjugate

Non-conjugated

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form

Liquid

Tested Applications

ELISA, Dot blot (guaranteed specific to the immunizing peptide)

Protocols

ELISA Protocol

Troubleshooting and FAQs

Antibody FAQs

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Value-added Deliverables

①. 100ug * KLH-conjugated peptide paired with 100ug * BSA-conjugated peptide (positive control);
②. 1ml*pre-immune serum (used as negative control) for free;
③. Rabbit polyclonal antibodies purified by Antigen Affinity;

Quality Guarantee

1. CUSABIO guarantees the antibody purity > 95% confirmed by SDS-PAGE.
2. CUSABIO guarantees the antibody titer > 1: 64,000 confirmed by ELISA.
3. CUSABIO guarantees to offer Peptide-specific Dot blot.
4. CUSABIO guarantees 100% risk-free: No qualified antibody, no charge.

Lead Time

Made-to-order (14-16 weeks)

Usage

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function

The phosphoenolpyruvate-dependent sugar phosphotransferase system (sugar PTS), a major carbohydrate active transport system, catalyzes the phosphorylation of incoming sugar substrates concomitantly with their translocation across the cell membrane. The enzyme II complex composed of GatA, GatB and GatC is involved in galactitol transport.

Subcellular Location

Cytoplasm.

Database Links

KEGG: ece:Z3257

STRING: 155864.Z3257

Promotions

Email: [email protected]
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Does Antibody-dependent Enhancement Occur in SARS-CoV-2 Infection? The True Face of Tumor Suppressor Gene p53 Cell Differentiation Determines the Fate of Cells TFR1 (TFRC): a Stimulator of Fe Transport Affects Anemia, Neurodegenerative Disorders and Cancers! Immune Activation: Insights into T Cell Differentiation Stem Cell-What a Miraculous Resource in Human Body Focus on Emerging Therapeutic Targets BCMA SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC! How do Th1 and Th2 Cells Differentiate? GIPR: the Crucial Regulator of Glucose and Lipid Metabolism in Diabetes and Obesity! PD-1-- An Important Immune Checkpoint CD Antigens - From Leucocytes Surface Markers to Diagnostic Markers for Cancer Another powerful addition to domestic IL-17A inhibitors! 3S Guojian's Anmoqitamab approved, with once-every-8-week dosing—a game-changer for psoriasis patients. PD-1/PD-L1, What a Powerful Immune Checkpoint Crosstalk Between Apoptosis and Autophagy: Molecular Mechanisms and Therapeutic Strategies in Cancer CADM1: an Immunoglobulin Superfamily Molecule, a New Tumor Suppressor Gene! IL-6: an Important Participant in the Inflammatory Cascade, One of the Most Functional Cytokines in Various Diseases Research! SIGLEC15: An Emerging Immune Checkpoint Target in Tumor Immunotherapy GPR20: From "Orphan" to a Promising Novel Target for Overcoming Drug-Resistant GIST PDGFRA: A Hub in Cellular Signaling and a Therapeutic Target Emerging Therapeutic Target ANGPTL4: A Key Molecule Linking Metabolism, Inflammation, and Tissue Remodeling Spanning Eight Major Cancers: Why Has Transmembrane Mucin MUC13 Become a New Focus in Precision Tumor Therapy? B2M/β2-Microglobulin: From Antigen Presentation Core to Key Target for Immunotherapy and Disease Prediction CDH1/E-cadherin: Research Progress on a Core Target from Adhesion Regulation to Tumor Therapy Overview of CCR4 Target: Core Roles in Physiological Functions and Pathological Regulation CD33 (Siglec-3) Signaling Pathways and Disease Mechanisms: Roles in Acute Myeloid Leukemia, Alzheimer’s Disease and Immune Regulation Beyond PD-1: CD96 is Becoming the Next "Battleground" in Immunotherapy Antibody FAQs What Is an Antibody? How to Choose an Antibody for Scientific Research? The difference between primary antibody and secondary antibod The Meaning of Irregular Antibody Screening Tag Antibodies, Your Good Partner in Protein Research How to Choose the Loading Control Antibodies?

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

[email protected]

Address

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Join us with

Subscribe newsletter

Leave a message

Message

Product >> Product Name：
Product >> Code：
Name： *
Email： *
Company/Organization：
Phone：
Since emails may get flagged by spam filters occasionally, we recommend leaving your phone number as a precaution. Your information is safe with us.
Question/Comment： *
Your Region： *
I'd like to receive email newsletters from Cusabio

Yes

No
How do you know CUSABIO?

Email

Distributor

Search engine

Advertisement

Others
CAPTCHA verification：
Please enter the characters shown. Click the image to refresh if unclear.

gatA Antibody

Product Details

Related Products

Customer Reviews and Q&A

Target Background